Esfahani, Shadi A.
Morris, Michael J.
Sartor, Oliver
Frydenberg, Mark
Fanti, Stefano
Calais, Jeremie
Vapiwala, Neha
Article History
Received: 18 March 2024
Accepted: 21 July 2024
First Online: 15 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: SE – No relevant competing interests. S.A.E. is supported by NCI K08CA259626 and has received research support from Sofie Biosciences, Telix and Novartis. MM – (none). OS - Received research or grant support from Advanced Accelerator Applications, Amgen, AstraZeneca, Bayer, Constellation, Endocyte, Invitae, Janssen, Lantheus, Merck, Progenics, Tenebio; is a consultant for Advanced Accelerator Applications (AAA), Amgen, ArtBio, Astellas, AstraZeneca, Bayer, Blue Earth Diagnostics, Inc., Clarity Pharmaceuticals, Clovis, Constellation, Convergent, Dendreon, EMD Serono, Foundation Medicine, Fusion, Genzyme, Hengrui, Isotopen Technologien Meunchen, Merck, Janssen, Morphimmune, Myovant, Myriad, Noria Therapeutics, Inc., NorthStar, Novartis, Noxopharm, Progenics, POINT Biopharma, Pfizer, Sanofi, Tenebio, Telix, Tessa, Theragnostics. MF – (none). SF – Grants/honoraria/travel support from AAA, Amgen, Astellas, AstraZeneca, Bayer, Debio, GE, Immedica, Janssen, Merck, Novartis, Sofie, Telix, Associate Editor of JNM, Editor of EJNMMI. JC - Reports prior consulting activities outside the submitted work for Advanced Accelerator Applications, Blue Earth Diagnostics, CuriumPharma, GE Healthcare, Janssen, POINT Biopharma, Progenics, Radiomedix, and Telix Pharmaceuticals. He is the recipient of grants from the Prostate Cancer Foundation (2020 Young Investigator Award 20YOUN05), the Society of Nuclear Medicine and Molecular Imaging (2019 Molecular Imaging Research Grant for Junior Academic Faculty), the Philippe Foundation Inc. (New York, USA), and the ARC Foundation (France) (International Mobility Award SAE20160604150).